Browse > Article

Identification of Lactobacillus ruminus SPM0211 Isolated from Healthy Koreans and Its Antimicrobial Activity against Some Pathogens  

Yun Ji-Hee (Department of Pharmacy, Sahmyook University)
Yim Dong-sool (Department of Pharmacy, Sahmyook University)
Kang Jin-Yang (Department of Pharmacy, Sahmyook University)
Kang Byung-Yong (Research Institute for Life Science, Sahmyook University)
Shin Eun-ah (Life Science and Biotechnology, Korea University)
Chung Myung-Jun (Cellbiotech, Co. Ltd.)
Kim Soo-Dong (Cellbiotech, Co. Ltd.)
Baek Dae-Heoun (Cellbiotech, Co. Ltd.)
Kim Kyungjae (Department of Pharmacy, Sahmyook University)
Ha Nam-Joo (Department of Pharmacy, Sahmyook University)
Publication Information
Archives of Pharmacal Research / v.28, no.6, 2005 , pp. 660-666 More about this Journal
Abstract
The intestinal microbiota are important to the host with regard to resistance they impart against bacterial infections and their involvement in mediating metabolic functions. Lactic acid producing bacteria such as Lactobacillus play an important physiological role in these matters. The aim of the present study was to isolate Lactobacillus sp. that inhibits enteric pathogens. Initially, 17 isolates from healthy Koreans were collected on Lactobacillus selective medium. Resistance of the isolates to antibiotics including rifampicin, streptomycin, clindamycin and vancomycin was measured. One of the isolate was identified as Lactobacillus ruminus on the basis of bacterial cell morphology, cultural characteristic and biochemical characteristics, 16S rRNA sequence analysis and PCR-RAPD. Antimicrobial activity of the bacterium against Vancomycin Intermediate Resistant Staphylococcus aureus (VISA) and Vancomycin-Resistant Enterococci (VRE) was measured. About $10^4$ cells of VISA or VRE were mixed with 1, 5, and 9 mL of L. ruminus SPM 0211 and the final volume was adjusted to 10 mL with brain heart infusion (BHI) broth. The cell suspension was incubated for 3, 6, 9, and 24 h, serially diluted and then plated on BHI agar plates. As numbers of L. ruminus SPM 0211 were increased, viable cell count of VISA and VRE decreased. The strongest antimicrobial activity of SPM 0211 was observed after 9 h incubation in any mixture, almost completely inhibiting the growth of these two bacteria. The results suggest that the freshly isolated L. ruminus SPM 0211 may be used as a pro-biotic microbe that prevents the colonization of enteric pathogens and can thereby promote good gastrointestinal health.
Keywords
Vancomycin; Lactobacillus ruminus; 16S-rRNA sequence; PCR-RAPD; Vancomycin Intermediate resistant; Staphylococcus aureus; Vancomycin-resistant; Enterococci;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By Web Of Science : 8  (Related Records In Web of Science)
Times Cited By SCOPUS : 7
연도 인용수 순위
1 Bae, H. G., Kim, S. O., Park, J. S., Kang, B. Y., Choi, S. S., Kang, J. Y., and Ha, N. J., Analysis of Genetic Diversity of Bifidobacterium sp. Isolated from Korean Adults Fecal Samples. Yakhak Hoieji, 48(1), 20-26 (2004)
2 Breslaw, E. S., Kleyn D. H., In vitro digestibility of protein in yoghurt at various stages of processing. J. Food Sci., 38, 1016 (1973)   DOI
3 Ha, K. H., Characterization of Vibrio parahaemolyticus Isolated from Diarrheal Patients and Environmental Sources by RAPD-PCR. J. Bacteriol. Virol., 34(1), 45-58 (1999)
4 Ha, N. J., Park, J. S., Yun, J. H., Jang, D. H., Kang, B. Y., Chung, M. J., Kim, S. D., Hong, O. P., and Choi, S. S., Genomic Fingerprinting of Bifidobacterium sp. Isolated from the Feces of Healthy Korean Adults using Microbial Microbial Uniprimer Kit. FASEB J., A992 (2004)
5 Kim, B. J., Gong, J. Y., Lee, C. S., and Lee, Y. H., Development of Remedy by for the Infectible Disease by Resistant Bacteria; Development of New Antibiotics with Antimicrobial Activity against Resistant Bacteria. Korea Research Institute Chemical Technology, 1-207 (2003)
6 Modler, H. W., Mckeller, R. C., and Yaguchi, M., Bifidobacteria and bifidogenic factors. Can. Inst. Food Sci. Technol. J., 23, 29-41 (1990)   DOI
7 Mullie, C., Odou, M. F., Singer, E., Romond, M. B., and Izard, D., Multiplex PCR using 16S rRNA gene-targeted primers for the identification of bifidobacteria from human origin. FEMS Microbiology Lett., 222, 129-136 (2003)   DOI   ScienceOn
8 Song, J. H., Emerging Infectious Disease due to Micorbial Adaptation: Emergence and Spread of Antimicrobial Resistance. Korean Society of Infection Disease, Infection and chemotherapy, 31(1), 79-87 (2002)
9 Venema, K. and Maathuis, J. H., A PCR-based method for identification of bifidobacteria from the human alimentary tract at the species level. FEMS Microbiology Lett., 224, 143-149 (2003)   DOI   ScienceOn
10 Yamashita, M., Hatano, M., Matsui, T., and Kumon, Y., Effects of Bifermin-Radmistered in combination with antibiotics on the fecal flora. Bifidobacteria Microflora, 4, 23 (1985)   DOI
11 Matsuki, T., Watanabe, K., Tanaka, R., and Oyaizu, H., Rapid identification of human intestinal bifidobacteria by 16S rRNAtargeted species- and group-specific primers. FEMS Microbiology Lett., 167, 113-121 (1998)   DOI   ScienceOn
12 Catherine, L. and Henry, F. C., Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrobial Agents and Chemotherapy, 47(10), 3040-3045 (2003)   DOI   ScienceOn
13 Sekine, K., Toida, T., Saito, M., Kuboyama, M., Kawashima, T., and Hashimoto, Y., A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Cancer Res., 45, 1300 (1985)
14 Mcdonel, J. L., Clostridium perfringens toxins (Type A, B, C, D, E). Pharmacol. Ther., 10, 617-655 (1980)   DOI   PUBMED   ScienceOn
15 National Committee for Clinical Labortory Standards (1988)
16 Park, S. G., Park, S. K., Jung, J. H., and Jin, Y. H., Antibiotic Susceptibility of Salmonella sp. Isolated From Diarrhoea Patients in Seoul From 1996 to 2001. J. Fd. Hyg. Safety, 17(2), 61-70 (2002)
17 Chun, U. H., Park, B. S., and Cho, J. S., Optimum Conditions for the Protoplast Formation of Lactobacillus plantarum and Lactobacillus plantarum. Korean J. Biotechnol. Bioeng., 9(2), 191-199 (1994)   과학기술학회마을
18 Yokoyama, M. T. and Carlson, J. R., Microbial metabolites of tryptophan in the intertinal tract with special reference to skatole. Am. J. Chin. Nutr., 32, 173-178 (1979)   DOI
19 Kang, B. Y., Yun, J. H., Chung, M. J., Kim, S. D., Hong, O. P., Kang, J. Y., Choi, S. S., and Ha, N. J., Isolation, Identification and Characterization of potential probiotic Bifidobacterium sp. from Healthy Korea Adults. J. Microbiol., 42(3), (2004)
20 Yu, H. J., Lee, S. S., Lee, D. S., and Kim, H. B., Isolation of Lactobacillus plantarum HB1 from Tongchimi and Its Nitrite-Scavenging Effect. Kor. J. Microbiol., 39(3), (2003)   과학기술학회마을
21 Mitsuoka, T., Bifidobacteria and their role in human health. J. Ind. Microbiol., 6, 263-268 (1990)   DOI
22 Lee, J. W., Epidemiological typing of Vancomycin-Resistant Streptococcus equines Isolated from Animal Foods by Microbial Uniprimer $Kit^{TM}$. (2002)
23 Committee on Treatment if International Union against Tuberculosis and Lung Disease: Antituberculosis regimens of chemotherapy. Bull. Int. Union Tuberc. Lung Dis., 63, 60 (1988)
24 Lee, K. M., Yun, J. H., Choi, S. S., and Ha, N. J., Comparison of environmental growth condition in Bifidobacterium sp. parent and It's mutants. J. Life Sci., 12, 113-121 (2004)
25 Lee, S. H., Park, N. Y., and Choi, W. J., Changes of the Lactic Acid Bacteria and Selective Inhibitive Substances against Homo and Hetero Lactic Acid bacteria Isolated from Kimchi. Kor. J. Appl. Microbiol. Biotechnol., 27(5), 410-414 (1999)
26 Fridkin, S. K., Vancomycin-intermediate and -resistant Staphylococcus aureus: What the infectious disease specialist needs to know. Clinical Infectious Diseases, 32(1), 108-115 (2001)   DOI   ScienceOn
27 Olivier, D., Claire, N., Baudouin, B., Christiane, K., Sophie, B. D., and Marc, J. St., Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. J. Antimicrobial Chemother., 50(3), 383-391 (2002)   DOI   ScienceOn
28 Woodford, N., Johnson, A. P., Morrison, D., and Speller, D. C. E., Current perspectives on glycopeptide resistance. Clin. Microbial Rev., 8, 585-615 (1995)
29 David, S. J., Jasmina, D., and Sean, P. G., The resistance of polyvinylpyrrolidone–Iodine–poly(-caprolactone) blends to adherence of Escherichia coli. Biomaterials, 26(14), 2013-2020 (2005)   DOI   ScienceOn
30 Kim, S. H., Keon, N. H., Kim, J. Y., Lim, J. Y., Bae, W. K., Kim, J. M., Noh, K. J., Hur, J., Jung, W. K., Park, K. T., Lee, J. E., Ra, J. C., and Park, Y. H., Antimicrobial Activity of Natural Product Made by Opuntia ficus-indica var. saboten Against Salmonella sp. and Escherichia coli O157:H7. J. Fd. Hyg. Safety, 17(2), 71-78 (2002)
31 Rhee, Y. K., Han, M. J., Choi, E. C., Kim, D. H., Hypocholesterolemic activity of Bifidobacteria isolated from a healthy Korean. Arch. Pharm. Res., 25, 681 (2002)   DOI   ScienceOn
32 Park, J. C., Kim, I. S., Kwon, S. K., Noh, J. M., Lee, S. M., Park, J. P., Lee, W. K., and Ryu, S. R., Prevalence of Antibiotic- Resistant Strains among Bacteria Isolated from Bovine Mastitis, Swine Diarrhea, and Swine Pneumonia. Kor. J. Appl. Microbiol. Biotechnol., 28(4), 189-194 (2000)   과학기술학회마을
33 Choi, E. H., Kim, H. Y., Kim, Y. H., Kim, W. K., Oh, S. J., and Kim, Y. H., Effects of Selected Oligosaccharides on Fecal Microflora and Lipid Constitution in Rats. Korean Nutrition society J., 32(3), 221-229 (1999)   과학기술학회마을